![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » TEVA PHARMA DOUBLES PROFIT, LIFTS FORECAST
TEVA PHARMA DOUBLES PROFIT, LIFTS FORECAST
August 9, 2006
Teva Pharmaceutical Industries Ltd. closed with a more than 5% gain after the Israeli drugmaker reported second-quarter net income that doubled on new U.S. product launches and sales derived from its recent acquisition of Ivax Corp. Market Watch (http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B32558619%2D61A4%2D4CFA%2D81D8%2D277D0FF5F3EB%7D&source=blq%2Fyhoo&dist=yhoo&siteid=yhoo)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct